|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.25 TWD | +0.48% |
|
+0.81% | +42.05% |
DR.Chip Biotechnology Incorporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 88.97 million compared to TWD 88.93 million a year ago. Net loss was TWD 28.22 million compared to TWD 17.2 million a year ago.
Basic loss per share from continuing operations was TWD 1.49 compared to TWD 0.91 a year ago. Diluted loss per share from continuing operations was TWD 1.49 compared to TWD 0.91 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +42.05% | 38.3M | |
| +75.35% | 12.55B | |
| -23.01% | 7.51B | |
| +8.35% | 6.74B | |
| +14.40% | 5.47B | |
| -14.85% | 4.89B | |
| +32.74% | 4.74B | |
| -23.06% | 2.9B | |
| +55.06% | 2.49B | |
| +0.25% | 1.99B |
NEOCORE TECHNOLOGY CO., LTD. 
